Evidence map›Paper›PMID 11756466›Full record

ArticleThe Journal of cell biology2001

Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration.

G Maheshwari, H S Wiley, D A Lauffenburger

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cell-Cell Contact and Receptor Tyrosine Kinase Signaling.Cold Spring Harbor perspectives in biology · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance.Journal of perinatology : official journal of the California Perinatal Association · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Microfluidics for mammalian cell chemotaxis.Annals of biomedical engineering · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

G MaheshwariDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
H S Wiley
D A Lauffenburger
Center for Cancer Research · USMassachusetts Institute of Technology · USPacific Northwest National Laboratory · US

Funding

USE OF GENETICALLY MODIFIED SKIN TO TREAT DISEASEP01HD028528 · NICHD · UNIVERSITY OF UTAH · PI KRUEGER, GERALD · 1992 to 2003
$4.6M
NICHD NIH HHS P01-HD28528
6 · The paper itself

Abstract

Cell responses to soluble regulatory factors may be strongly influenced by the mode of presentation of the factor, as in matrix-bound versus diffusible modes. The possibly diverse effect of presenting a growth factor in autocrine as opposed to exogenous (or paracrine) mode is an especially important issue in cell biology. We demonstrate here that migration behavior of human mammary epithelial cells in response to stimulation by epidermal growth factor (EGF) is qualitatively different for EGF presented in exogenous (paracrine), autocrine, and intracrine modes. When EGF is added as an exogenous factor to the medium of cells that express EGF receptor (EGFR) but not EGF, cell migration speed increases while directional persistence decreases. When these EGFR-expressing cells are made to also express via retroviral transfection EGF in protease-cleaveable transmembrane form on the plasma membrane, migration speed similarly increases, but directional persistence increases as well. Addition of exogenous EGF to these cells abrogates their enhanced directional persistence, reducing their directionality to a level similar to wild-type cells. If the EGFR-expressing cells are instead transduced with a gene encoding EGF in a soluble form, migration speed and directional persistence were unaffected. Thus, autocrine presentation of EGF at the plasma membrane in a protease-cleavable form provides these cells with an enhanced ability to migrate persistently in a given direction, consistent with their increased capability for organizing into gland-like structures. In contrast, an exogenous/paracrine mode of EGF presentation generates a "scattering" response by the cells. These findings emphasize the functional importance of spatial restriction of EGFR signaling, and suggest critical implications for growth factor-based therapeutic treatments.

Indexed as

Autocrine CommunicationBreastCell LineCell MovementCulture Media, Serum-FreeEpidermal Growth FactorEpithelial CellsErbB ReceptorsFemaleFluorescent DyesHumansMicroscopy, FluorescenceSignal TransductionCulture Media, Serum-FreeEpidermal Growth FactorErbB ReceptorsFluorescent Dyes

Identifiers

PMID11756466
PMCPMC2199328
OpenAlexW2083275631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.